PFCS
RGNX icon

Pale Fire Capital SE’s Regenxbio RGNX Stock Holding History

Pale Fire Capital SE’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.59M Sell
466,209
-27,517
-6% -$228K 0.39% 26
2026
Q1 		$4.14M Sell
493,726
-5,800
-1% -$60.9K 0.36% 23
2025
Q4 		$7.19M Buy
499,526
+243,925
+95% +$3.04M 0.48% 16
2025
Q3 		$2.47M Buy
255,601
+227,755
+818% +$2.01M 0.27% 22
2025
Q2 		$229K Buy
27,846
+2,000
+8% +$16.7K 0.02% 41
2025
Q1 		$185K Buy
25,846
+14,125
+121% +$105K 0.02% 38
2024
Q4 		$90.6K Buy
+11,721
New +$110K 0.02% 46

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Pale Fire Capital SE's RGNX Position: Q2 2026 in Review

Pale Fire Capital SE reduced its Regenxbio (RGNX) stake by 5.6% in Q2 2026, selling an estimated $228K and leaving 466,209 shares worth $5.59M. The position accounts for 0.39% of the portfolio, ranked #26.

Pale Fire Capital SE first reported a position in RGNX in Q4 2024 and has held it in 7 quarters since. The position peaked at $7.19M in Q4 2025. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Pale Fire Capital SE held 466,209 shares of Regenxbio worth $5.59M as of Q2 2026.
  • Pale Fire Capital SE sold 27,517 Regenxbio shares in Q2 2026, an estimated $228K.
  • Regenxbio made up 0.39% of Pale Fire Capital SE's portfolio in Q2 2026, its #26 holding.
  • Pale Fire Capital SE first reported a position in Regenxbio in Q4 2024 and has held it in 7 quarters since.
  • Pale Fire Capital SE's Regenxbio position peaked at $7.19M in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Pale Fire Capital SE's 13F filing for Q2 2026, filed 13 Aug 2026.